Pretreatment with topical betamethasone in ahmed glaucoma valve implantatio
Not Applicable
- Conditions
- Glaucoma.Glaucoma
- Registration Number
- IRCT20180902040928N1
- Lead Sponsor
- Basir eye health research center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 108
Inclusion Criteria
Patients with no age limit with IOPs less than target pressure in whom glaucoma drainage implant (GDI) surgery was planned were enrolled in the study
Exclusion Criteria
Exclusion criteria were no light perception at baseline
history of ocular surface infection in recent two weeks
pregnancy
breast feeding
lack of healthy conjunctiva for AGV insertion
sensitivity to betamethasone eye drop
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Intraocular pressure. Timepoint: first day, first week, month 1, 3, 6, 9 and 12 after the surgery. Method of measurement: Goldman applanation tonometry.
- Secondary Outcome Measures
Name Time Method umber of eyes requiring medications. Timepoint: first day, first week, month 1, 3, 6, 9 and 12 after the surgery. Method of measurement: Quantitative.;Number of medications. Timepoint: first day, first week, month 1, 3, 6, 9 and 12 after the surgery. Method of measurement: Quantitative.;Best corrected visual acuity (BCVA). Timepoint: first day, first week, month 1, 3, 6, 9 and 12 after the surgery. Method of measurement: tumbling E-chart.;Complications. Timepoint: first day, first week, month 1, 3, 6, 9 and 12 after the surgery. Method of measurement: qualitative.